Table 4.

Multiple logistic regression analyses of urinary polycyclic aromatic hydrocarbon metabolites and hypertension.

Metabolite	Adjusted odds ratioa	95% confidence interval	p for trend
1-Hydroxypyrene			0.716
≤ 25th percentile	1 (Reference)
25–50th percentile	1.072	0.742–1.548
50–75th percentile	1.235	0.882–1.728
> 75th percentile	0.876	0.626–1.227
Continuousb	0.912	0.791–1.052
2-Hydroxyfluorene			0.568
≤ 25th percentile	1 (Reference)
25–50th percentile	1.152	0.807–1.645
50–75th percentile	0.934	0.667–1.308
> 75th percentile	1.292	0.839–1.989
Continuousb	1.105	0.949–1.287
1-Hydroxyphenanthrene			0.002
≤ 25th percentile	1 (Reference)
25–50th percentile	1.334	0.930–1.916
50–75th percentile	1.707	1.203–2.423
> 75th percentile	1.604	1.158–2.223
Continuousb	1.241	1.063–1.449
2-Naphthol			0.634
≤ 25th percentile	1 (Reference)
25–50th percentile	0.944	0.696–1.280
50–75th percentile	0.876	0.657–1.169
> 75th percentile	0.967	0.699–1.339
Continuousb	0.963	0.879–1.055

^aAdjusted for age, sex, BMI, smoking status, and drinking status.

^bLog-transformed concentration of urinary PAH metabolite.